NAYA - NAYA Biosciences Inc. Quarterly EPS earnings growth
NAYA Biosciences develops unique antibodies to combat tumors, protecting its innovations with FLEX-NK patents. The quarterly EPS growth history confirms this potential, where the value 79.80 represents the current figure. Management is focused on raising capital to advance therapy development, while optimizing biomaterial supplies in stable regions minimizes the company's operational risks.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwhdatcg.m7-7dqbc3k&start=20220704&end=20261115&filename=GURU_Markets_-_NAYA_-_NAYA-Biosciences_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "NAYA Biosciences Inc (NAYA): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 04/28/2025 | 👁️GURU.Markets👁️")
Analytical breakdowns for NAYA Biosciences
- market value and analyst target forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Total Debt to Equity Ratio NAYA Biosciences|NAYA - Long-Term Liabilities to Capital|Short-Term Debt to Capital nayabiosciences.com|NAYA - Company Aggregate Debts|Debt to Book Value NAYA Biosciences Inc.|NAYA - Company Long-Term Loans and Borrowings|Company Short-Term Debts NAYA Biosciences|Quick Ratio nayabiosciences.com
- earnings and market multiples details:
NAYA - Net Financial Result|Expected Profit NAYA Biosciences|NAYA - Market Cap to Earnings|Future Price to Earnings nayabiosciences.com|NAYA - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple NAYA Biosciences Inc.|NAYA - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) NAYA Biosciences|NAYA - Net earnings per share for the last four quarters|Quarterly EPS earnings growth nayabiosciences.com|NAYA - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year NAYA Biosciences
- company sales and revenue statistics:
Initial company analysis:NAYA Bio, NAYA
This indicator calculates the percentage change in net earnings per share compared to the same period last year, reflecting the dynamics of the business's actual earnings. For NAYA Biosciences (NAYA), which is in a stage of costly development without sales, the current quarterly EPS growth value on the GURU.Markets platform serves as a marker for the rate of capital expenditure and the company's degree of financial stability.
Who NAYA Biosciences competes with
ONC: Quarterly EPS earnings growth|Halozyme Inc. - Year-over-year earnings per one share growth for the last 12 months|RVMD (Revolution Medicines Inc) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ascentage Pharma Group AAPG|Quarterly EPS earnings growth CGON|Quarterly EPS earnings growth UroGen Pharma Ltd (URGN)|Quarterly EPS earnings growth BCAX (Bicara Corp)|Personalis Genomics (PSNL) - Earnings per share growth in annualized terms for the last twelve months|Erasca Oncology - Quarterly EPS earnings growth|DCTH: Year-over-year earnings per share growth for the last twelve months|YMAB: Quarterly EPS earnings growth|Aura Bio (AURA) - Quarterly EPS earnings growth|CADL (Candel Therapeutics Inc.) - Quarterly EPS earnings growth|ARAY: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months SLS (SELLAS Life Sciences Group, Inc.)|Year-over-year earnings per share growth rate for the last twelve months ACTU|Citius Oncology - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months HURA|TARA: Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months Fate Pharma|Aadi Bioscience Inc (WHWK) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months TScan (TCRX)|Year-over-year net earnings per share growth for the last 12 months CSBR|xbiotech.com (XBIT) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months cel-sci.com (CVM)|OSTX - Earnings per share growth in annualized terms for the last twelve months|Radiopharm Theranostics - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months ARTV|ANL - Year-over-year earnings per share growth for the last twelve months|VERU - Quarterly EPS earnings growth|Tempest Therapeutics, Inc. (TPST) - Year-over-year earnings per share growth for the last twelve months|XLO: Year-over-year earnings per share growth rate for the last twelve months|RENB (Renovaro Biosciences) - Quarterly EPS earnings growth|MURA: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KAPA (Kairos Pharma Ltd)|Year-over-year earnings per share growth rate for the last twelve months OKUR|CytoMed Therapeutics Limited - Year-over-year net earnings per share growth for the last 12 months|CRIS: Year-over-year earnings per share growth for the last 12 months|APLM - Year-over-year earnings per share growth for the last twelve months|THAR - Quarterly EPS earnings growth|ADVB: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months SBFM|Quarterly EPS earnings growth XBIO|Year-over-year net earnings per share growth for the last 12 months Salarius Pharmaceuticals SLRX|Quarterly EPS earnings growth PPBT (Purple Biotech Ltd)|AONC - Year-over-year net earnings per share growth for the last 12 months|BGNE: Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months Checkpoint Therapeutics, Inc CKPT|ELEV: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months iCAD Inc. (ICAD)|IKNA (Ikena) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Notable Labs (NTBL)|Quarterly EPS earnings growth VIRX|Year-over-year net earnings per share growth for the last 12 months MorphoSys Corporation MOR|Quarterly EPS earnings growth AAPGV (Ascentage)
